• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 5,6,7,8-四氢吡啶并[4,3-d]嘧啶的 TASK-3 通道拮抗剂的结构/活性分析。

Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.

机构信息

Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile. El Llano Subercaseaux 2801-Piso 6, 7500912 Santiago, Chile.

Centro de Bioinformática y Simulación Molecular (CBSM), Universidad de Talca. 1 Poniente No. 1141, 3460000 Talca, Chile.

出版信息

Int J Mol Sci. 2019 May 7;20(9):2252. doi: 10.3390/ijms20092252.

DOI:10.3390/ijms20092252
PMID:31067753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6539479/
Abstract

TASK-3 potassium (K) channels are highly expressed in the central nervous system, regulating the membrane potential of excitable cells. TASK-3 is involved in neurotransmitter action and has been identified as an oncogenic K channel. For this reason, the understanding of the action mechanism of pharmacological modulators of these channels is essential to obtain new therapeutic strategies. In this study we describe the binding mode of the potent antagonist PK-THPP into the TASK-3 channel. PK-THPP blocks TASK-1, the closest relative channel of TASK-3, with almost nine-times less potency. Our results confirm that the binding is influenced by the fenestrations state of TASK-3 channels and occurs when they are open. The binding is mainly governed by hydrophobic contacts between the blocker and the residues of the binding site. These interactions occur not only for PK-THPP, but also for the antagonist series based on 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine scaffold (THPP series). However, the marked difference in the potency of THPP series compounds such as 20b, 21, 22 and 23 (PK-THPP) respect to compounds such as 17b, inhibiting TASK-3 channels in the micromolar range is due to the presence of a hydrogen bond acceptor group that can establish interactions with the threonines of the selectivity filter.

摘要

TASK-3 钾 (K) 通道在中枢神经系统中高度表达,调节可兴奋细胞的膜电位。TASK-3 参与神经递质作用,已被确定为致癌性 K 通道。因此,了解这些通道的药理学调节剂的作用机制对于获得新的治疗策略至关重要。在这项研究中,我们描述了强效拮抗剂 PK-THPP 与 TASK-3 通道的结合模式。PK-THPP 对 TASK-1 的抑制作用(TASK-3 的最接近的相关通道)弱近九倍。我们的结果证实,结合受 TASK-3 通道的窗孔状态影响,并且仅在通道开放时发生。结合主要受阻滞剂与结合位点残基之间的疏水接触控制。这些相互作用不仅发生在 PK-THPP 中,也发生在基于 5,6,7,8 四氢吡啶并[4,3-d]嘧啶骨架的拮抗剂系列(THPP 系列)中。然而,THPP 系列化合物如 20b、21、22 和 23(PK-THPP)与化合物如 17b 的效力存在显著差异,后者以微摩尔范围抑制 TASK-3 通道,这是由于存在氢键受体基团,可与选择性过滤器的苏氨酸建立相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/6d66bd029a20/ijms-20-02252-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/62f3850ae61c/ijms-20-02252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/cf0187a34e1c/ijms-20-02252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/7f4ebbcf9bf0/ijms-20-02252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/c0e8d4d85057/ijms-20-02252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/c9c455166c28/ijms-20-02252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/6d66bd029a20/ijms-20-02252-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/62f3850ae61c/ijms-20-02252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/cf0187a34e1c/ijms-20-02252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/7f4ebbcf9bf0/ijms-20-02252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/c0e8d4d85057/ijms-20-02252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/c9c455166c28/ijms-20-02252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ed/6539479/6d66bd029a20/ijms-20-02252-g006.jpg

相似文献

1
Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.基于 5,6,7,8-四氢吡啶并[4,3-d]嘧啶的 TASK-3 通道拮抗剂的结构/活性分析。
Int J Mol Sci. 2019 May 7;20(9):2252. doi: 10.3390/ijms20092252.
2
TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.TASK-1(KCNK3)和 TASK-3(KCNK9)串联孔钾通道拮抗剂可刺激异氟烷麻醉大鼠的呼吸。
Anesth Analg. 2013 Apr;116(4):810-6. doi: 10.1213/ANE.0b013e318284469d. Epub 2013 Mar 4.
3
Discovery of a pharmacologically active antagonist of the two-pore-domain potassium channel K2P9.1 (TASK-3).发现双孔钾通道 K2P9.1(TASK-3)的一种具有药理活性的拮抗剂。
ChemMedChem. 2012 Jan 2;7(1):123-33. doi: 10.1002/cmdc.201100351. Epub 2011 Sep 14.
4
5-(Indol-2-yl)pyrazolo[3,4-]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis.5-(吲哚-2-基)吡唑并[3,4-b]吡啶类作为 TASK-3 通道阻断剂的新家族:基于药效团的区域选择性合成。
Molecules. 2021 Jun 25;26(13):3897. doi: 10.3390/molecules26133897.
5
Yeast strain Saccharomyces cerevisiae BYT45 lacking the cation extrusion systems ENA1-5 and NHA1 is suitable for the characterization of TASK-3 potassium channel antagonists.酵母菌株 Saccharomyces cerevisiae BYT45 缺失阳离子外排系统 ENA1-5 和 NHA1,适合用于 TASK-3 钾通道拮抗剂的特性分析。
FEMS Yeast Res. 2019 Aug 1;19(5). doi: 10.1093/femsyr/foz044.
6
A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore.一种特定的双孔域钾通道阻断剂定义了 TASK-1 开放孔的结构。
J Biol Chem. 2011 Apr 22;286(16):13977-84. doi: 10.1074/jbc.M111.227884. Epub 2011 Mar 1.
7
Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.侧窗为A1899与TASK-1钾通道孔的稳定结合提供了一个“锚点”。
Mol Pharm. 2017 Jul 3;14(7):2197-2208. doi: 10.1021/acs.molpharmaceut.7b00005. Epub 2017 May 30.
8
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.呼吸刺激化合物可能通过结合于通道孔的一个共同位点来抑制TASK-3钾通道功能。
Mol Pharmacol. 2015 Nov;88(5):926-34. doi: 10.1124/mol.115.100107. Epub 2015 Aug 12.
9
Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening.基于药效团的虚拟筛选发现新型 TASK-3 通道阻断剂。
Int J Mol Sci. 2019 Aug 17;20(16):4014. doi: 10.3390/ijms20164014.
10
Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3.靶向 TASK-3 双孔钾通道的线粒体抑制剂的合成及细胞效应。
Pharmacol Res. 2021 Feb;164:105326. doi: 10.1016/j.phrs.2020.105326. Epub 2020 Dec 15.

引用本文的文献

1
Advances in the Understanding of Two-Pore Domain TASK Potassium Channels and Their Potential as Therapeutic Targets.双孔域 TASK 钾通道的理解进展及其作为治疗靶点的潜力。
Molecules. 2022 Nov 28;27(23):8296. doi: 10.3390/molecules27238296.
2
Tandem pore domain acid-sensitive K channel 3 (TASK-3) regulates visual sensitivity in healthy and aging retina.串联孔结构域酸敏感钾通道3(TASK-3)调节健康和衰老视网膜中的视觉敏感性。
Sci Adv. 2022 Sep 9;8(36):eabn8785. doi: 10.1126/sciadv.abn8785. Epub 2022 Sep 7.
3
Two-Pore-Domain Potassium (K-) Channels: Cardiac Expression Patterns and Disease-Specific Remodelling Processes.

本文引用的文献

1
The molecular basis for an allosteric inhibition of K-flux gating in K channels.K 通道中变构抑制 K 流门控的分子基础。
Elife. 2019 Feb 26;8:e39476. doi: 10.7554/eLife.39476.
2
A pharmacological master key mechanism that unlocks the selectivity filter gate in K channels.一种药理学万能钥匙机制,可打开 K 通道的选择性滤器门。
Science. 2019 Feb 22;363(6429):875-880. doi: 10.1126/science.aav0569.
3
Binding of Tolperisone Hydrochloride with Human Serum Albumin: Effects on the Conformation, Thermodynamics, and Activity of HSA.
双孔钾通道(K-):心脏表达模式和疾病特异性重塑过程。
Cells. 2021 Oct 27;10(11):2914. doi: 10.3390/cells10112914.
4
5-(Indol-2-yl)pyrazolo[3,4-]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis.5-(吲哚-2-基)吡唑并[3,4-b]吡啶类作为 TASK-3 通道阻断剂的新家族:基于药效团的区域选择性合成。
Molecules. 2021 Jun 25;26(13):3897. doi: 10.3390/molecules26133897.
5
Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance.神经肽S受体刺激通过膜钾电导的钙依赖性降低来兴奋小鼠基底外侧杏仁核中的主要神经元。
Pharmaceuticals (Basel). 2021 May 27;14(6):519. doi: 10.3390/ph14060519.
6
Screening for Interacting Proteins with Peptide Biomarker of Blood-Brain Barrier Alteration under Inflammatory Conditions.筛选与炎症条件下血脑屏障改变的肽生物标志物相互作用的蛋白质。
Int J Mol Sci. 2021 Apr 29;22(9):4725. doi: 10.3390/ijms22094725.
7
Structural Insights into the Mechanisms and Pharmacology of K Potassium Channels.钾离子通道的结构机制与药理学研究进展
J Mol Biol. 2021 Aug 20;433(17):166995. doi: 10.1016/j.jmb.2021.166995. Epub 2021 Apr 20.
8
Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening.基于药效团的虚拟筛选发现新型 TASK-3 通道阻断剂。
Int J Mol Sci. 2019 Aug 17;20(16):4014. doi: 10.3390/ijms20164014.
盐酸托培酮与人血清白蛋白的结合:对 HSA 构象、热力学和活性的影响。
Mol Pharm. 2018 Apr 2;15(4):1445-1456. doi: 10.1021/acs.molpharmaceut.7b00976. Epub 2018 Mar 6.
4
K2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site.K2.1(TREK-1)激活剂复合物揭示了一个隐藏的选择性过滤器结合位点。
Nature. 2017 Jul 20;547(7663):364-368. doi: 10.1038/nature22988. Epub 2017 Jul 10.
5
First universal pharmacophore model for hERG1 K channel activators: acthER.首个针对人醚 - 去极化激活钾离子通道1(hERG1 K通道)激活剂的通用药效团模型:促hERG1 K通道激活模型(acthER)
J Mol Graph Model. 2017 Jun;74:153-170. doi: 10.1016/j.jmgm.2017.03.020. Epub 2017 Apr 5.
6
Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.侧窗为A1899与TASK-1钾通道孔的稳定结合提供了一个“锚点”。
Mol Pharm. 2017 Jul 3;14(7):2197-2208. doi: 10.1021/acs.molpharmaceut.7b00005. Epub 2017 May 30.
7
Biophysical Study on the Interaction between Eperisone Hydrochloride and Human Serum Albumin Using Spectroscopic, Calorimetric, and Molecular Docking Analyses.利用光谱、量热和分子对接分析对盐酸乙哌立松与人血清白蛋白相互作用的生物物理研究
Mol Pharm. 2017 May 1;14(5):1656-1665. doi: 10.1021/acs.molpharmaceut.6b01124. Epub 2017 Apr 17.
8
Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.新型N-烯丙基/炔丙基四氢喹啉:通过三组分阳离子亚胺狄尔斯-阿尔德反应合成、结合预测及作为胆碱酯酶抑制剂的评价
Chem Biol Drug Des. 2016 Oct;88(4):498-510. doi: 10.1111/cbdd.12773. Epub 2016 Jun 6.
9
Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.使用对接、定量构效关系、分子动力学和MM-GBSA研究凝血酶抑制剂的差异活性
PLoS One. 2015 Nov 24;10(11):e0142774. doi: 10.1371/journal.pone.0142774. eCollection 2015.
10
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.呼吸刺激化合物可能通过结合于通道孔的一个共同位点来抑制TASK-3钾通道功能。
Mol Pharmacol. 2015 Nov;88(5):926-34. doi: 10.1124/mol.115.100107. Epub 2015 Aug 12.